更年期症状全面评估量表的信度与效度评价

doi:10.3969/j.issn.1006-7795.2021.04.002

首都医科大学学报 ›› 2021, Vol. 42 ›› Issue (4): 511-520.doi: 10.3969/j.issn.1006-7795.2021.04.002

• 绝经、妇科内分泌与生育力保护 • 上一篇下一篇

更年期症状全面评估量表的信度与效度评价

张凌燕¹, 阮祥燕^1*, 李星明², 崔亚美¹, 谷牧青¹, 刘玉兰¹, 甄洁¹

1.首都医科大学附属北京妇产医院内分泌科,北京 100026;
2.首都医科大学公共卫生学院卫生管理与政策学系,北京 100069

收稿日期:2021-05-18 出版日期:2021-08-21 发布日期:2021-07-29
基金资助:
国家自然科学基金(81671411),北京市医院管理中心登峰计划(DFL20181401), 国家更年期保健特色专科建设单位[(2020)30],首批北京市级妇幼保健专科示范单位“更年期保健专科”[(2017)35号]。

Evaluation of reliability and validity of the Comprehensive Assessment of Menopausal Symptoms Scale

Zhang Lingyan¹, Ruan Xiangyan^1*, Li Xingming², Cui Yamei¹, Gu Muqing¹, Liu Yulan¹, Zhen Jie¹

1. Department of Gynecological Endocrinology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, China;
2. Department of Health Mangement and Policy, School of Public Health, Capital Medical University, Beijing 100069, China

Received:2021-05-18 Online:2021-08-21 Published:2021-07-29
Contact: * E-mail:ruanxiangyan@ccmu.edu.cn
Supported by:
National Natural Science Foundation of China (81671411), Beijing Municipal Administration of Hospitals' Ascent Plan (DFL20181401), National Menopause Health Care Specialist Construction Unit of China [(2020)30], Beijing Municipal Health Commission [(2017)35].

摘要/Abstract

摘要： 目的本研究旨在探讨中国女性更年期症状全面评估量表的信度与效度。方法于2018年至2020年期间收集了2 487 名年龄在40~83岁之间的中国女性的数据。采用临界比值法、Cronbach's α系数法、因子分析法对更年期症状量表的条目进行筛选。结果确定量表的概念框架:更年期症状量表包括负面情绪和认知症状、肢体活动障碍、性相关症状、生殖系统症状、自主神经紊乱症状、关节肿痛、肢体感觉异常、精力减退症状、泌尿系统症状、血管舒缩症状及睡眠障碍等11个维度。构建条目池:形成的条目池包括54个条目。通过探索性因子分析提取出10个因子,其累计方差贡献率为61.28%。更年期量表总的Spearman-Brown相关系数为0.866,Guttman Split-half为0.852,相关系数为0.763,Cronbach's alpha 系数范围为0.778~0.914。结论初步证明为中国女性开发的更年期症状全面评估量表是一种有效可靠的工具,其结构模型合理,条目具有较好的内部一致性和历时稳定性,可以更全面地测量我国更年期女性相关心理症状,具有潜在的推广应用前景。临床工作者可以利用此量表测量更年期患者的症状,进而对其进行相应的干预并评价干预效果。

关键词: 更年期症状, 量表, 信度, 效度

Abstract: Objective To investigate the reliability and validity of the Comprehensive Assessment Scale for Menopausal Symptoms in Chinese women. Methods The data were collected from 2 487 Chinese women aged 40-83 between 2018 and 2020. The critical ratio method, Cronbach's alpha coefficient method and factor analysis method were used to screen the items of menopausal symptom scale. Results The conceptual framework of the scale was define with 11 dimensions included in the Menopause Symptom Scale: negative emotional and cognitive symptoms, limb dyskinesia, sex-related symptoms, reproductive symptoms, autonomic nervous disorder symptoms, joint swelling and pain, limb paresthesia, energy loss symptoms, urinary symptoms, vasomotor symptoms, and sleep disorders. The pool consisting of 54 entries was constructed. Ten factors were extracted by exploratory factor analysis, and their cumulative variance contribution rate was 61.28%. The total Spearman-Brown correlation coefficient was 0.866, Guttman Split-half was 0.852, the correlation coefficient was 0.763, and the Cronbach's alpha coefficient range was 0.778-0.914. Conclusion The comprehensive assessment scale for menopausal symptoms developed for Chinese women has proved to be an effective and reliable tool with reasonable structure model, good internal consistency and diachronic stability of items, which can measure the related psychological symptoms of Chinese menopausal women more comprehensively and has potential application prospects. Clinicians can use this scale to measure the symptoms of menopausal patients, and then intervene accordingly and evaluate the intervention effect.

Key words: menopausal symptoms, scale, reliability, validity

中图分类号:

张凌燕, 阮祥燕, 李星明, 崔亚美, 谷牧青, 刘玉兰, 甄洁. 更年期症状全面评估量表的信度与效度评价[J]. 首都医科大学学报, 2021, 42(4): 511-520.

Zhang Lingyan, Ruan Xiangyan, Li Xingming, Cui Yamei, Gu Muqing, Liu Yulan, Zhen Jie. Evaluation of reliability and validity of the Comprehensive Assessment of Menopausal Symptoms Scale[J]. Journal of Capital Medical University, 2021, 42(4): 511-520.

参考文献

[1] 朱雅玲,张彬.人口结构变动下中国消费的未来趋势——基于第七次全国人口普查数据的分析[J].陕西师范大学学报(哲学社会科学版): 2021,50(4):163-176.
[2] Al-Safi Z A, Santoro N. Menopausal hormone therapy and menopausal symptoms[J]. Fertil Steril, 2014, 101(4):905-915.
[3] Berg J A, Larson C A, Pasvogel A E. Menopausal symptom perception and severity: results from a screening questionnaire[J]. J Clin Nurs, 2008,17(7):940-948.
[4] Williams R E, Kalilani L, Dibenedetti D B, et al. Healthcare seeking and treatment for menopausal symptoms in the United States[J]. Maturitas,2007,58(4):348-358.
[5] Nelson H D. Menopause[J]. Lancet,2008,371(9614):760-770.
[6] Moilanen J, Aalto A M, Hemminki E, et al. Prevalence of menopause symptoms and their association with lifestyle among finnish middle-aged women[J]. Maturitas,2010,67(4):368-374.
[7] No author listed. ACOG Practice Bulletin No. 141: management of menopausal symptoms[J]. Obstet Gynecol,2014,123(1):202-216.
[8] Ruan X, Cui Y M, Mueck A O. Prevalence of climacteric symptoms in China comparing peri- and postmenopausal women[J]. Maturitas,2015,81(1):147.
[9] Im E O. The Midlife Women's Symptom Index (MSI).[J]. Health Care for Women Int,2006,27(3):268-287.
[10] Fu S Y, Anderson D, Courtney M. Cross-cultural menopausal experience: Comparison of Australian and Taiwanese women[J]. Nurs Health Sci, 2010,5(1):77-84.
[11] Harlow S D, Gass M, Hall J E, et al. Executive summary of the Stages of Reproductive Aging Workshop+10: addressing the unfinished agenda of staging reproductive aging[J]. Climacteric, 2012,15(2):105-114.
[12] Portman D J, Gass M L S. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society[J]. Menopause,2014,21(10):1063-1068.
[13] Cohen L S, Soares C N, Vitonis A F, et al. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles[J]. Arch Gen Psychiatry,2006,63(4):385-390.
[14] Heinemann K, Ruebig A, Potthoff P, et al. The Menopause Rating Scale (MRS) scale: a methodological review[J]. Health and quality Life Outcomes,2004,2:45.
[15] Tabachnick B R G, Fidell L S. Using multivariate statistics[M]. New York: Pearson,2001.
[16] Pallant J. SPSS survival manual: a step by step guide to data analysis using SPSS for Windows[J]. Austr N Z J Public Health,2013,37(6):597-598.
[17] 赵秋利,刘维维,吴燕妮. 护理测评工具的开发与应用[M]. 北京:人民卫生出版社,2014.
[18] 德威利斯,魏勇刚,龙长权,等. 量表编制:理论与应用[M]. 重庆:重庆大学出版社,2004.
[19] Ayers B, Forshaw M, Hunter M S. The impact of attitudes towards the menopause on women's symptom experience: a systematic review[J]. Maturitas,2010,65(1):28-36.
[20] Gold E B, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation[J]. Am Public Health,2006,96(7):1226-1235.
[21] Defey D, Storch E, Cardozo S, et al. The menopause: women's psychology and health care[J]. Soc Sci Med,1996,42(10):1447-1456.
[22] Hall L, Callister L C, Berry J A, et al. Meanings of menopause: cultural influences on perception and management of menopause[J]. J Holits Nur,2007,25(2):106-180.
[23] 吴明隆. SPSS统计应用实务:问卷分析与应用统计[M]. 北京:科学出版社,2003.
[24] Polo-Kantola P. Sleep problems in midlife and beyond[J]. Maturitas,2011,68(3):224-232.
[25] Chedraui P, Pérez-López F R, Morales B, et al. Depressive symptoms in climacteric women are related to menopausal symptom intensity and partner factors[J]. Climacteric,2009,12(5):395-403.
[26] Yen J U, Yang M A, Wang M U, et al. The associations between menopausal syndrome and depression during pre-, peri-, and postmenopausal period among Taiwanese female aborigines[J]. Psychiatry Clin Neurosic, 2010,63(5).
[27] Zhang L, Ruan X, Cui Y, et al. Menopausal symptoms among Chinese peri- and postmenopausal women: a large prospective single-center cohort study[J]. Gynecol Endocrinol, 2021,37(2):185-189.

更年期症状全面评估量表的信度与效度评价

Evaluation of reliability and validity of the Comprehensive Assessment of Menopausal Symptoms Scale

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	许新, 阮祥燕, 鞠蕊, 杨瑜, 程姣姣, 王志坤, Alfred O. Mueck. 中国女性轻度认知障碍的影响因素及其与绝经症状的关系[J]. 首都医科大学学报, 2022, 43(3): 369-374.
[2]	刘怡均, 林向英, 张燕. 中文版世界卫生组织生存质量测定量表简表用于终末期肾病的信效度验证[J]. 首都医科大学学报, 2021, 42(4): 635-641.
[3]	鞠蕊, 阮祥燕, 许新, 杨瑜, 张露平, 秦爽, 王宾红, 豆竹丽, Alfred O. Mueck. 围绝经期及绝经后女性性功能障碍状况及与更年期症状的关系分析[J]. 首都医科大学学报, 2020, 41(4): 503-507.
[4]	宋楠, 贾竑晓. 人格解体患者认知功能及与临床症状和社会功能的相关性[J]. 首都医科大学学报, 2020, 41(1): 59-63.
[5]	徐波, 杨丽娟, 李占江. 睡眠功能失调性信念与态度量表中文版的信效度研究[J]. 首都医科大学学报, 2019, 40(5): 665-670.
[6]	苏雪, 李占江, 龙鲸, 祖思, 张燕波, 徐波. 怀特利指数中文版的信度效度分析[J]. 首都医科大学学报, 2019, 40(5): 671-676.
[7]	戴琳, 温玉成, 路桃影, 蔡坚雄, 王立新, 秦敏, 吴大嵘. 简短版中医健康量表和欧洲五维健康量表在脑卒中患者中的测量特性评价[J]. 首都医科大学学报, 2019, 40(4): 627-634.
[8]	唐煜, 郝单单, 秦玮婷, 文潇, 李放. 轻度阿尔茨海默病患者年龄对蒙特利尔认知评估量表基本版得分的影响[J]. 首都医科大学学报, 2019, 40(4): 652-655.
[9]	尹冬青, 黄芳, 赵安全, 王群松, 马雁冰, 陈进东, 李宝君, 都弘, 贾竑晓. 精神分裂症中医证候要素诊断量表初步研究[J]. 首都医科大学学报, 2018, 39(6): 821-827.
[10]	王培培, 莫少华, 马昕宇, 张嘉玲, 徐志卿, 王静. 结合自评量表和认知任务测量医学生抑郁情绪[J]. 首都医科大学学报, 2018, 39(6): 889-893.
[11]	翟倩, 胡昌清, 杨丽, 张国富, 王晶晶, 刘敏. 社会支持情况与精神障碍相关性研究[J]. 首都医科大学学报, 2018, 39(5): 646-650.
[12]	杜娟, 阮祥燕, Alfred O. Mueck. 口服避孕药对多囊卵巢综合征患者性功能的影响[J]. 首都医科大学学报, 2018, 39(4): 499-504.
[13]	赵经纬, 罗旭颖, 徐明, 石广志, 周建新. 全面无反应量表在重症动脉瘤性蛛网膜下腔出血预后评估中的应用[J]. 首都医科大学学报, 2018, 39(1): 28-34.
[14]	金凤羽, 阮祥燕, Alfred O. Mueck, 刘玉兰, 杜娟. 北京及周边地区围绝经期女性性功能现状调查分析[J]. 首都医科大学学报, 2017, 38(4): 509-514.
[15]	李峰, 薄奇静, 赵燕, 刘辉, 王传跃. 重性抑郁障碍病人生活质量及其影响因素[J]. 首都医科大学学报, 2017, 38(2): 186-191.